C hronic kidney disease (CKD) has been shown to be an independent risk factor for cardiovascular disease in general populations.
C hronic kidney disease (CKD) has been shown to be an independent risk factor for cardiovascular disease in general populations. 1 Recently, we have shown that even slight renal dysfunction, with an estimated glomerular filtration rate (eGFR) of 50 to 59 mL/min per 1.73 m 2 , results in an increased risk of cardiovascular disease in an urban general population. 2 One possible explanation for the association of CKD with cardiovascular disease is that CKD-related nontraditional risk factors accelerate atherosclerosis independent of traditional vascular risk factors. 3 However, there is controversy as to whether CKD is independently associated with carotid intimamedia thickness (IMT). 4 This may be because the impact of CKD, especially mild kidney disease, on carotid atherosclerosis is somewhat limited. CKD seems to increase the risk of carotid atherosclerosis when hypertension and impaired glucose metabolism are present. 5 We hypothesized that the impact of CKD on carotid atherosclerosis differs according to the presence of concomitant cardiovascular risk factors. Thus, we aimed to clarify the association of CKD with carotid atherosclerosis and the impact of CKD on carotid atherosclerosis according to blood pressure (BP) categories in an urban general population.
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carotid atherosclerosis was defined as follows. Max-IMT was defined as the maximum IMT in the entire scanned area. Stenosis was defined as the presence of a stenotic area ≥25% on a cross-sectional scan. The eGFR was calculated using equations recommended by the Japanese Society of Nephrology. 6 The subjects were categorized into 4 groups (eGFR ≥90, 60-89, 50-59, and <50 mL/min per 1.73 m 2 ) as in our previous study. 2 CKD was defined as an eGFR <60 mL/min per 1.73 m 2 . BP categories (optimal, normal, high-normal BP, and hypertension) were based on the European Society of Hypertension and European Society of Cardiology 2007 criteria. 7 The association of eGFR category with carotid atherosclerosis and the association of CKD with carotid atherosclerosis according to BP categories were examined using analysis of covariance and logistic regression analysis, after adjusting for cardiovascular risk factors as covariates (see Methods in the online-only Data Supplement).
Results
CKD was identified in 16.2% (eGFR=50-59: 10.9%; eGFR<50: 5.3%) of men and in 10.5% (7.4%, 3.1%) of women (see Table I in the online-only Data Supplement.). The multivariable-adjusted max-IMT and odds ratio for stenosis in subjects with eGFR<50 were significantly greater than those in subjects with eGFR≥90; however, the max-IMT and odds ratio in subjects with eGFR=50 to 59 were not significantly different from those in subjects with eGFR≥90 (Tables 1 and  2 ). Consequently, the max-IMT and odds ratio for stenosis in the whole CKD sample were not significantly greater than those in the eGFR≥90 group.
When subjects were stratified according to BP categories, the multivariable-adjusted max-IMT in the hypertension category was significantly greater in both sexes. The max-IMT was significantly greater in CKD subjects than in non-CKD subjects only in subjects with hypertension ( Figure [A] ). The prevalence of stenosis was higher in subjects with high-normal BP and hypertension in all subjects. The impact of CKD on the prevalence of stenosis was more pronounced in subjects with hypertension (multivariable-adjusted odds ratio 
Discussion
In our study, CKD was independently associated with carotid atherosclerosis in subjects with hypertension, but not in nonhypertensive subjects. This is the first study to show the combined impact of CKD and hypertension on carotid atherosclerosis in an urban general population.
In previous studies in general populations, only one study reported that reduced kidney function was a strong predictor of greater carotid IMT at baseline and progression of carotid atherosclerosis independent of vascular risk factors. 8 Another study found no independent association of eGFR with carotid IMT. 9 In our study, eGFR <50 mL/min per 1.73 m 2 was independently associated with carotid atherosclerosis, whereas CKD was not. The inconsistent results of these studies might be attributable in part to different eligibility criteria, background, or methods for evaluating renal function. An alternative explanation is that the association of CKD with carotid atherosclerosis may be somewhat limited. In a recent Japanese study, CKD was associated with increased IMT only in subjects with hypertension. 5 Similarly, we showed that CKD was independently associated with carotid atherosclerosis in subjects with hypertension, whereas there was no significant impact of CKD in nonhypertensive subjects. Our results suggest that the impact of CKD on carotid atherosclerosis differs according to the presence of concomitant vascular risk factors. CKD may not directly contribute to early carotid atherosclerosis but may rather accelerate the development of atherosclerosis in the setting of progressive endothelial dysfunction in those with hypertension.
We could not demonstrate a causal relationship between CKD, hypertension, and carotid atherosclerosis because of the crosssectional design of our study. However, carotid atherosclerosis reflects the cumulative effects of cardiovascular risk factors that are present over many years. In the future, we plan to determine whether the coexistence of CKD and hypertension increases the risk of carotid atherosclerosis in a prospective study.
In conclusion, the association of CKD with carotid atherosclerosis was modest, but CKD was independently associated with carotid atherosclerosis in subjects with hypertension in an urban general population. Our results suggest that the presence of hypertension should be considered for risk stratification of CKD for improved stroke prevention. 
Evaluation of renal function
Serum creatinine (Cr) was measured by the kinetic Jaffé method. The estimated glomerular filtration rate (eGFR) was calculated from the Cr value and age, using equations recommended by the Japanese Society of Nephrology. 
Carotid Ultrasound Measurements
Carotid atherosclerosis was evaluated by high-resolution ultrasonography with a 7.5-MHz transducer that produced an axial resolution of 0.1 mm. We measured the carotid arteries from the superior border of the collarbone to the inferior margin of the mandible. Details of the methods used for the carotid ultrasonic examination have been previously published.
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Measurement of Blood Pressure
Well-trained physicians measured blood pressure (BP) three times with the subject in a seated position using a mercury column sphygmomanometer, an appropriately sized cuff and a standard protocol. Before the initial BP reading was obtained, participants were seated at rest for at least 5 minutes. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were taken as the average of the second and third measurements, which were separated by more than 1 minute. Subjects were the SBP and DBP readings for a subject were in different categories, the subjects were categorized into the higher of the two BP categories.
Covariates
We performed routine blood tests that included serum total cholesterol, HDL cholesterol and glucose levels. Fasting serum glucose categories were defined as follows 6 
Statistical analysis
The association of GFR category with carotid atherosclerosis index was examined using analysis of covariance (ANCOVA) to compare the maximum intima-media thickness among subjects according to GFR category. In addition, logistic regression analysis was to estimate odds ratios (OR) and 95% confidence intervals (CI) for the relationship between stenosis and each GFR category, 
